GlaxoSmithKline: Q4 Earnings Insights

GlaxoSmithKline GSK reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

GlaxoSmithKline beat estimated earnings by 6.15%, reporting an EPS of $0.69 versus an estimate of $0.65.

Revenue was up $1.22 billion from the same period last year.

Last quarter the company beat on EPS by $0.2, which was followed by a 4.21% increase in the share price the next day.

Here's a look at GlaxoSmithKline's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	0.81	0.57	0.61	0.64
EPS Actual	1.01	0.79	0.63	0.62
Revenue Estimate	11.88B	10.54B	11.06B	11.60B
Revenue Actual	12.44B	11.33B	10.24B	11.62B

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar